All Articles

The following are a selection of key clinical trials that are currently recruiting patients for inclusion in investigations of new therapies and new regimens of available therapies for patients with multiple myeloma. Each clinical trial description includes the NLM Identifier to be used as a reference with ClinicalTrials.gov. The information below can help oncology practice managers and providers direct their eligible patients to one of these clinical trials.

Within the multidisciplinary team, the navigator works as an advocate, care provider, educator, counselor, and facilitator to ensure that every patient receives comprehensive, timely, and quality healthcare services.

The authors present a case study highlighting the importance of patients’ physical and mental preparedness for the recommended medical treatments.

Navigators need to advance their knowledge of genomics and maintain competence with the continuing advancements in order to provide education to patients and their families on the impact of genomics in their cancer care so they can make the best informed decisions.

The role of the navigator along the continuum of care is bidimensional in nature with a patient-centered (empowerment with education and knowledge) and health system (multidisciplinary) orientation to deliver timely, seamless care.

As all navigation programs are built uniquely, we encourage you to rate your program as you feel appropriate.

Survivorship medicine has never been in more demand, but questions regarding reimbursement remain.

A new paradigm of survivorship care is needed that attempts to balance the patient’s total well-being against the often toxic treatment of the disease, suggests Deborah Korenstein, MD, Director of Clinical Effectiveness, Memorial Hospital, Memorial Sloan Kettering Cancer Center, New York City.

Linking physicians and patients is a major undertaking, but given the ubiquity of smartphone technology and the rise in app development, the healthcare industry is poised to leverage advances in communication and information exchange.

The American Society of Clinical Oncology (ASCO) maintains that a multidisciplinary team (MDT) is the cornerstone of quality care, yet despite incentives and interest, little is known about how teams affect cancer delivery.